2004
DOI: 10.1056/nejmoa033534
|View full text |Cite
|
Sign up to set email alerts
|

A Randomized Trial of a Single Dose of Oral Dexamethasone for Mild Croup

Abstract: For children with mild croup, dexamethasone is an effective treatment that results in consistent and small but important clinical and economic benefits. Although the long-term effects of this treatment are not known, our data support the use of dexamethasone in most, if not all, children with croup.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
90
0
6

Year Published

2006
2006
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 170 publications
(98 citation statements)
references
References 24 publications
2
90
0
6
Order By: Relevance
“…The overall evidence suggests that the oral delivery of dexamethasone at a dose of 0.3 mg/kg for moderate croup up to 0.6 mg/kg for severe croup as a single dose is helpful in decreasing symptoms at 6, 12, and 24 hours after treatment, decreasing the need to use nebulized epinephrine, reducing the length of stay in the ED and resulting in fewer hospital admissions. 36,39,40 The onset of action of dexamethasone may be clinically apparent as soon as 30 minutes after its administration. 41 In a patient who is not vomiting, there is little evidence to suggest that parenteral administration is superior to oral administration.…”
Section: Croupmentioning
confidence: 99%
“…The overall evidence suggests that the oral delivery of dexamethasone at a dose of 0.3 mg/kg for moderate croup up to 0.6 mg/kg for severe croup as a single dose is helpful in decreasing symptoms at 6, 12, and 24 hours after treatment, decreasing the need to use nebulized epinephrine, reducing the length of stay in the ED and resulting in fewer hospital admissions. 36,39,40 The onset of action of dexamethasone may be clinically apparent as soon as 30 minutes after its administration. 41 In a patient who is not vomiting, there is little evidence to suggest that parenteral administration is superior to oral administration.…”
Section: Croupmentioning
confidence: 99%
“…Other rigorously designed studies support the use of parental recall via telephone follow-up with respect to reports on physician visits within the time frame used in this study. , 17,18 Families were asked about the following details related to the index fracture: clinical status, pain (never, occasionally, often, or always) and return to usual activities (always, most of the time, some of the time, not very often, or never); type (if any) of physician follow-up; parent management of splint usage and return to activities; and physician visits and diagnostic imaging taken after the ED visit, with respective changes in diagnosis/treatment. Families were also asked about their satisfaction with PCP follow-up and PCP-recommended time frames for splint usage and return to usual activities.…”
Section: Follow-upmentioning
confidence: 99%
“…Bjornson a étudié l'efficacité de la dexaméthasone pour traiter le croup dans une étude randomisée contrôlée portant sur 720 enfants. 28 Une dose unique de 0,6 mgÁkg -1 de dexaméthasone a été donnée à l'urgence, et aucun événement néfaste n'a été rapporté lors du rendez-vous de suivi, 21 jours plus tard. Cette dose est considérablement plus élevée que la dose généralement administrée en période périopératoire.…”
Section: Innocuité Deunclassified
“…Bjornson studied the efficacy of dexamethasone to treat croup in a randomized controlled trial of 720 children. 28 A single 0.6 mgÁkg -1 dose of dexamethasone was given in the emergency department, and there were no reports of any adverse events on follow-up after 21 days. This dose is significantly greater than the dose typically used in the perioperative period.…”
mentioning
confidence: 96%